Thyroid Gland Adenocarcinoma — Trials

Thyroid Gland Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

195 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 17
Ph III recruiting: 4
Growth YoY: —
Industry share: 7%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05014698	IDEntification of New Predisposition Genes in Differentiated THYroid Cancer(IDENTHY-K)	terminated	N/A	34	Nantes University HospitalOTHER	1	Jan 28, 2026	clinicaltrials
NCT05003856	Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule	terminated	N/A	1	M.D. Anderson Cancer CenterOTHER	1	Apr 2, 2025	clinicaltrials